NEWS On the Health Affairs Blog: Assessing the Value of Treatments for Rare Diseases Presents Several Unique Challenges 4/12/17

In the latest post on the IVI-sponsored Health Affairs blog series, IVI's Darius Lakdawalla and Anupam Jena recommend that creators of value frameworks recognize the unique issues associated with valuing treatments for rare diseases by adopting societal, as well payer-oriented perspectives. Included in this assessment are the important roles of treatment spillovers, societal preferences about health equity, and the insurance value of innovation.

Read more here.